On September 7, 2022 Herantis Pharma Plc ("Herantis"), developing disease modifying therapies for Parkinson’s disease, reported that CEO Antti Vuolanto and CFO Tone Kvåle will be presenting and holding 1×1 meetings at the Nordic Life Science Days (NLS) in Malmö, Sweden on September 28-29, 2022 (Press release, Herantis Pharma, SEP 7, 2022, View Source;sweden,c3627059 [SID1234619121]). Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentations will be accessible to event participants only. If you are interested in scheduling a 1×1 meeting with Herantis management you can contact the conference organizers, connect with us via the Nordic Life Science Days 1×1 platform, and/or send an email to [email protected].